Indo Us Bio-Tech Ltd
BSE:541304
Indo Us Bio-Tech Ltd
BSE:541304
Price:
99
INR
-0.3%
Market Closed
Market Cap:
₹2B
Balance Sheet
Balance Sheet Decomposition
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd
Balance Sheet Decomposition is not available for
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd
Balance Sheet
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd
Currency: INR
| Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
1
|
0
|
2
|
11
|
2
|
|
| Cash |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
1
|
0
|
2
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| Total Receivables |
27
|
20
|
66
|
57
|
90
|
103
|
225
|
261
|
234
|
328
|
202
|
150
|
|
| Accounts Receivables |
20
|
13
|
58
|
51
|
90
|
91
|
210
|
247
|
205
|
247
|
190
|
150
|
|
| Other Receivables |
7
|
6
|
8
|
6
|
0
|
12
|
15
|
14
|
28
|
80
|
12
|
0
|
|
| Inventory |
21
|
41
|
53
|
51
|
62
|
107
|
91
|
119
|
234
|
269
|
517
|
707
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
48
|
61
|
120
|
109
|
153
|
212
|
319
|
381
|
468
|
599
|
731
|
867
|
|
| PP&E Net |
10
|
11
|
12
|
12
|
15
|
25
|
27
|
43
|
79
|
87
|
105
|
102
|
|
| PP&E Gross |
10
|
11
|
12
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
8
|
8
|
7
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
9
|
3
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
2
|
5
|
4
|
4
|
4
|
0
|
0
|
3
|
6
|
8
|
9
|
9
|
|
| Total Assets |
61
N/A
|
77
+27%
|
137
+78%
|
125
-8%
|
171
+37%
|
239
+39%
|
347
+45%
|
437
+26%
|
556
+27%
|
695
+25%
|
845
+22%
|
978
+16%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
17
|
26
|
53
|
36
|
45
|
21
|
79
|
88
|
27
|
14
|
44
|
12
|
|
| Short-Term Debt |
16
|
12
|
45
|
44
|
49
|
48
|
74
|
72
|
68
|
84
|
104
|
104
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
23
|
15
|
11
|
15
|
|
| Other Current Liabilities |
7
|
5
|
2
|
2
|
10
|
18
|
17
|
10
|
5
|
10
|
16
|
33
|
|
| Total Current Liabilities |
39
|
43
|
99
|
82
|
104
|
87
|
170
|
180
|
123
|
123
|
175
|
163
|
|
| Long-Term Debt |
0
|
5
|
6
|
9
|
14
|
7
|
5
|
33
|
37
|
17
|
28
|
29
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
4
|
6
|
7
|
8
|
11
|
10
|
14
|
1
|
|
| Total Liabilities |
40
N/A
|
48
+21%
|
106
+122%
|
90
-14%
|
122
+35%
|
100
-18%
|
183
+83%
|
221
+21%
|
171
-23%
|
150
-13%
|
217
+45%
|
193
-11%
|
|
| Equity | |||||||||||||
| Common Stock |
12
|
15
|
15
|
15
|
34
|
49
|
61
|
61
|
92
|
100
|
201
|
201
|
|
| Retained Earnings |
9
|
14
|
16
|
20
|
15
|
91
|
104
|
155
|
293
|
445
|
427
|
585
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
21
N/A
|
29
+38%
|
31
+7%
|
35
+13%
|
49
+41%
|
139
+181%
|
164
+18%
|
215
+31%
|
385
+79%
|
545
+42%
|
627
+15%
|
785
+25%
|
|
| Total Liabilities & Equity |
61
N/A
|
77
+27%
|
137
+78%
|
125
-8%
|
171
+37%
|
239
+39%
|
347
+45%
|
437
+26%
|
556
+27%
|
695
+25%
|
845
+22%
|
978
+16%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
5
|
5
|
6
|
6
|
7
|
7
|
15
|
15
|
18
|
20
|
20
|
20
|
|
Switch to:
Switch to:
See Also
Discover More
